SCHEMBL15526430

SCHEMBL15526430

Cc1cc2nc(-c3nc(Br)cs3)sc2c(-c2ccc(Cl)cc2)c1C(C)(OC(C)(C)C)C(=O)O

nearest known ligand 0.34

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
SLC22A12 Q96S37 1/20 0.32
RAB9A P51151 3/20 0.31
KDM4E B2RXH2 2/20 0.31
NPC1 O15118 2/20 0.31
SMN1; SMN2 Q16637 2/20 0.31
POLB P06746 1/20 0.31
PPARD Q03181 2/20 0.31
SHMT1 P34896 2/20 0.31
MEN1 O00255 1/20 0.30
KMT2A Q03164 1/20 0.30
GAA P10253 1/20 0.30
DHODH Q02127 1/20 0.30
PPARA Q07869 1/20 0.30
SHMT2 P34897 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15526431 1.00 SLC22A12 (0.32) SLC22A12RAB9AKDM4ENPC1SMN1; SMN2
SCHEMBL15332821 0.81 CYP3A4 (0.42) RAB9AKDM4ENPC1SMN1; SMN2POLB
SCHEMBL19894349 0.81 KMO (0.34) SLC22A12RAB9AKDM4ENPC1SMN1; SMN2
SCHEMBL15333479 0.78 CYP3A4 (0.34) RAB9AGAA
SCHEMBL15333481 0.78 CYP3A4 (0.34) RAB9AGAA
SCHEMBL15526293 0.78 SMN1; SMN2 (0.33) SLC22A12RAB9AKDM4ENPC1SMN1; SMN2
SCHEMBL15342426 0.77 CYP3A4 (0.34) RAB9AKDM4ENPC1SMN1; SMN2POLB
SCHEMBL15331869 0.77 ABL1 (0.39)
SCHEMBL17530332 0.74
SCHEMBL17530325 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2788336-A1 BENZOTHIAZOL- 6 -YL ACETIC ACID DERIVATIVES AND THEIR USE FOR TREATING AN HIV INFECTION Gilead Sciences, Inc. (US) 2014-10-15 EP disclosed
WO-2013159064-A1 BENZOTHIAZOL- 6 -YL ACETIC ACID DERIVATIVES AND THEIR USE FOR TREATING AN HIV INFECTION GILEAD SCIENCES, INC. (US) 2013-10-24 WO disclosed